Chronic urticaria practical recommendations for management

Clinical Immunotherapeutics

Volumn 6, Issue 5, 1996, Pages 341-351

  O'Donnell, Brigid F ^a   Lawlor, Frances ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ADRENALIN; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; CHLORPHENIRAMINE; CYCLOSPORIN; DIPHENHYDRAMINE; DOXEPIN; EPHEDRINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; IMMUNOGLOBULIN; LORATADINE; TERFENADINE;

CHRONIC URTICARIA; HISTAMINE RELEASE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029826292     PISSN: 11727039     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03259355     Document Type: Article

References (63)

1. Champion RH. Roberts SOB, Carpenter RG. et al. Urticaria and angio-oedema: a review of 554 patients. Br J Dennatol 1969 Aug:81 (8): 588-97
2. Greaves MW. Chronic urticaria. New Engl J Med 1995 Jun 29; 332(26): 1767-72
3. Soter NA. Acute and chronic urticaria and angioedema. J Am Acad Dermatol 1991 Jul: 25 ( 1 Pt 2): 146-54
4. Dover JS. Kobza Black A, Milt'ord Ward A, et al. Delayed pressure urticaria: clinical features, laboratory investigations, and response to therapy of 44 patients. J Am Acad Dermatol 1988 Jun; 18(6): 1289-98
5. Lawlor F. Kobza Black A, Greaves MW. Delayed pressure urticaria, cold urticaria, chronic urticaria. Br J Dermatol 1988: HSlSuppl. 33): 91
6. ft. Barlow RJ. Warbuton F, Watson K. et al. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol 1993 Dec; 29 (6): 954-8
7. Champion RH. Urticaria: then and now. Br J Dermatol 1988: 119:427-36
8. Czarnetzki BM. Angioedema. In: Czarnetzki BM, editor. Urticaria. Berlin. Heidelberg. New York. Tokyo: Springer-Verlag. 1986:47-54
9. Bain BJ. Catovsky D. Ewan PW. Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes. Cancer 1993 Dec 1: 72 ( 11 ): 3318-22
10. Jawinska EC. Gatenby PA. Dunckley H. et al. Cl inhibitor functional deficiency in systemic lupus erythematosus (SLE) Clin Exp Immunol 1993 May; 92 (2): 268-73
11. Cohen SH. Koethe SM, Kozin F. et al. Acquired angioedema associated with rectal carcinoma and its response to danaJ.ol. Acquired angioedema treated with danazol. J Allergy Clin Immunol 1978 Oct: 62 (4): 217-21
12. Valient K, Feher J, Somogyi A, el al. Angioneurotic edema and hypocomplementemia in patients with thyroid cancer [in German]. Acta ChirAcad Sei Hung 1982;23(3): 163-71
13. Kobza Black A, Greaves MW, Champion RH. The urticarias 1990. BrJDermatol 1991 Jan; 124(1): 100-8
14. Greaves MW, O'Donnell BF. Chronic urticaria [letter]. Br J Dermatol 1995Jun; 132(6): 1023
15. Soter NA. The investigation of urticaria and angio-oedema [abstract]. Clin Exp Dermatol 1995; 20: 272-3
16. Michaelsson G, Juhlin L. Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol 1973 Jun; 88 (6): 525-32
17. Supramaniam G, Warner JO. Artificial food additive intolerance in patients with angio-oedema and urticaria. Lancet 1986 Oct 18; 2 (8512): 907-9
18. Hannuksela M, Lahti A. Peroral challenge tests with food additives in urticaria and atopic dermatitis. Int J Dermatol 1986 Apr; 25 (3): 178-80
19. Asad SI, Kemeny DM, Youlten LJ, et al. Effect of aspirin in aspirin sensitive' patients. BMJ 1984 Mar 10; 288 (6419): 745-8
20. Schoenfeld MR. Acute allergic reactions to morphine, codeine, meperidine hydrochloride and opium alkaloids. N Y State J Med 1960; 60: 2591
21. Wood SM, Mann RD, Rawlins MD. Angio-oedema and urticaria associated with angiotensin converting enzyme inhibitors. BMJ 1987 Jan 10; 294 (6564): 91-2
22. Grattan GEH, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria: a clinical, immunological and histological evaluation. Br J Dermatol 1986; 114: 583-90
23. Hide M, Francis DM, Barr RM, et al. Skin mast cell activation by autoantibodies in urticaria and therapeutic implications. In: Kitamura Y, Yamamoto S, Galli SJ, et al., editors. Biological and molecular aspects of mast cell and basophil differentiation and function. New York: Raven Press, 1995: 183-92
24. Grattan CEH, Francis DM, Hide M, et al. Detection of histamine releasing autoantibodies with functional properties of antiIgE in chronic urticaria. Clin Exp Allergy 1991; 21: 695-704
25. Francis DM, Niimi N, Hide M, et al. Histamine release from human skin in vitro induced by sera containing IgG antiFceRla autoantibodies from patients with chronic urticaria [abstract]. J Invest Dermatol 1994 Sep; 103 (3): 399
26. Grattan CEH. Hamon CGB, Cowan MA, et al. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. BrJ Dermatol 1988; 119: 179-84
27. Hide M, Francis DM, Grattan CEH, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. New Engl J Med 1993 Jun 3; 328 (22): 1599-604
28. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989 Jul; 84 ( 1 ): 66-71
29. Grattan CEH, Francis DM, Slater NGP, et al. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992 May 2; 339: 1078-80
30. Neittaanmaki H. Cold urticaria: clinical findings in 220 patients. J Am Acad Dermatol 1985 Oct; 13 (4): 636-44
31. Commens CA, Greaves MW. Tests to establish the diagnosis in cholinergic urticaria. Br J Dermatol 1978 Jan; 98 ( 1 ): 47-51
32. Greaves MW, Sneddon IB, Smith AK, et al. Heat urticaria. Br J Dermatol 1974: 90: 289-92
33. Czarnetzki BM. The physical urticarias. In: Czarnetzki BM, editor. Urticaria. Berlin, Heidelberg, New York, Tokyo: Springer-Verlag, 1986: 55-88
34. Lawlor F, Black AK, Breathnach AS, et al. Vibratory angiooedema: lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy. Br J Dermatol 1989 Jan; 120(1): 93-9
35. Simons FER, Simons KJ. The pharmacology and use of HIreceptor-antagonist drugs. New Engl J Med 1994 Jun 9; 330 (23): 1663-70
36. Nicholson AN, Pascoe PA, Turner C, et al. Sedation and HI receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br J Pharmacol 1991 Sep; 104(1): 270-6
37. Simons FER. H]-receptor antagonists: comparative tolerability and safety. Drug Saf 1994; 10 (5): 350-80
38. Boggs PB, Ellis CN, Grossman J, et al. Double-blind, placebocontrolled study of terfenadine and hydroxyzine in patients with chronic idiopathic urticaria. Ann Allergy 1989 Dec; 63 (6 Pt 2): 616-20
39. Woosley RL, Chen Y, Freiman JP, et al. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993 Mar 24-31; 269 (12): 1532-6
40. Honig PK, Wortham DC, Zamani K, et al. Terfenadine-ketoconazole interaction: pharmacokinetic andelectrocardiographic consequences. JAMA 1993 Mar 24-31; 269 (12): 1513-8
41. Honig PK, Woosley RL, Zamani K, et al. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycm. Clin Pharmacol Ther 1992 Sep; 52 (3): 231-8
42. Rampe D, Wible B. Brown AM. et al. Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart. Mol Pharmacol 1993 Dec; 44 (6): 1240-5
43. Committee on Safety of Medicines. Ventricular arrhythmias due to terfenadine and astemizole. Curr Probl Pharmacovig 1992 Nov; 35: 1-2
44. Stricker BH, Van Dijke CP, Isaacs AJ, et al. Skin reactions to terfenadine. BMJ 1986 Äug 30; 293 (6546): 536
45. Rao KA, Adlakha A, Verma-Ansil B, et al. Torsades de pointes ventricular tachycardia associated with overdose of astemizole. Mayo Clin Proc 1994 Jun; 69: 589-93
46. Janssens MM. Astemizole: a non-sedating antihistamine with fast and sustained activity. Clin Rev Allergy 1993; 11 (1): 35-63
47. Gengo FM, Gabos C. Antihistamines, drowsiness, and psychomotor impairment: central nervous system effect of cetirizine. Ann Allergy 1987 Dec; 59 (6 Pt 2): 53-7
48. Matzke GR, Yeh J. Awni WM, et al. Pharmacokinetics of cetirizine in the elderly and patients with renal insufficiency. Ann Allergy 1987 Dec; 59 (6 Pt 2): 25-30
49. Michel L, De Vos C, Rihoux JP, et al. Inhibitory effect of oral cetirizine on in vivo antigen induced histamine and PAFacether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988 Jul; 82: 101-9
50. Gaillard AWK, Gruisen A, de Jong R. The influence of antihistamines on human performance. Eur J Clin Pharmacol 1988; 35 (3): 249-53
51. Miadonna A, Milazzo N, Lorini M, et al. Inhibitory effect of the Hi antagonist loratadine on histamine release from human basophils. Int Arch Allergy Immunol 1994; 105: 12-7
52. Manna VK, Marks P, Gibson JR. An evaluation of the antihistamine activity of acrivastine and its onset in human skin. J Int Med Res 1992; 20: 106-11
53. Juhlin L. Landor M. Drug therapy for chronic urticaria. Clin Rev Allergy 1992: 10: 349-69
54. Kennard CD. Ellis CN. Pharmacologie therapy for urticaria. J Am Acad Dermatol 1991 Jul; 25 (1 Pt 2): 176-89
55. Monroe EW. Urticaria. Curr Probl Dermatol 1993 Jul-Aug: 5 (4): 115-40
56. Fradin MS, Ellis CN, Goldfarh MT, et al. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991 Dec: 25 (6 Pt 1): 1065-7
57. Barlow RJ, Kohza Black A. Greaves MW. Treatment of severe, chronic urticaria with cyclosporin A. Eur J Dermatol 1993 May: 3: 273-5
58. O'Donnell BF, Barlow RJ, Kohza Black A, et al. Response of severe chronic urticaria to intravenous immunoglobulin (IVIG) [abstract). Br J Dermatol 1994 Jul; 131 Suppl. 44: 23-4
59. Lawlor F. Kobza Black A, Milford Ward A. et al. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine. Br J Dermatol 1989: 120: 403-8
60. Wong E. Eftekari N. Greaves MW, el ul. Beneficial effects of danazol on symptoms and laboratory changes in cholinergic urticaria. Br J Dermatol 1987 Apr: 116 (4): 553-6
61. Lawlor F. Urticaria: diagnosis and treatment. In: Holgate ST. Church MK. editors. Allergy. London. New York: Cower Medical Publishing. 1993: 22.1-22.12
62. Berg RE, Kantor GR, Bergfeld WF. Urticarial vasculitis [review]. Int J Dermatol 1988 Sep: 27 (7): 468-72
63. O'Donnell B. Black AK. Urticarial vasculitis [review]. Int Angiol 1995 Jun; 14(2): 166-74